Alcon (ALC) Cash from Investing Activities (2009 - 2026)
Alcon (ALC) posted quarterly Cash from Investing Activities of -$218.0 million for Q1 2026, up 27.33% on a QoQ basis from -$300.0 million in Q4 2025.
Alcon (ALC) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Cash from Investing Activities for 11 consecutive years, with -$218.0 million the latest figure, recorded in Q1 2026.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$218.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$984.0 million (changed N/A YoY) and the FY2025 annual result came in at -$1.3 billion, down 15.17% from the prior year.
- Cash from Investing Activities rose to -$218.0 million in Q1 2026 per ALC's latest filing, from -$300.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ALC reached as high as -$133.0 million in Q2 2024 and fell as low as -$852.0 million in Q4 2022.
- A 5-year average of -$319.4 million and a median of -$275.5 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 360.31% — and 2023, when it jumped 74.3%.
- Year by year, Cash from Investing Activities stood at -$852.0 million in 2022, then soared by 56.1% to -$374.0 million in 2023, then advanced by 10.96% to -$333.0 million in 2024, then increased by 9.91% to -$300.0 million in 2025, then advanced by 27.33% to -$218.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$218.0 million, -$300.0 million, and -$312.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.72 Bn | 121.51 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.88 Bn | 44.07 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 33.19 Bn | 31.53 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.91 Bn | 30.67 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.22 Bn | 22.79 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 11.94 Bn | 9.92 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.00 Mn |
| Mar 31, 2026 | -218.00 Mn |
| Dec 31, 2025 | -300.00 Mn |
| Dec 31, 2025 | -300.00 Mn |
| Sep 30, 2025 | -312.00 Mn |
| Sep 30, 2025 | -312.00 Mn |
| Jun 30, 2025 | -154.00 Mn |
| Jun 30, 2025 | -154.00 Mn |
| Dec 31, 2024 | -333.00 Mn |
| Dec 31, 2024 | -333.00 Mn |
| Sep 30, 2024 | -483.00 Mn |
| Sep 30, 2024 | -483.00 Mn |
| Jun 30, 2024 | -133.00 Mn |
| Jun 30, 2024 | -133.00 Mn |
| Mar 31, 2024 | -218.00 Mn |
| Mar 31, 2024 | -218.00 Mn |
| Dec 31, 2023 | -374.00 Mn |
| Dec 31, 2023 | -374.00 Mn |
| Sep 30, 2023 | -152.00 Mn |
| Sep 30, 2023 | -152.00 Mn |